Michael Bronfein, Baltimore Business Leader and Curio Wellness Founder, Dies at 70

Michael G. Bronfein, a Randallstown native who built a decades-long career across banking, retail and health care, died Jan. 21 at age 70. Bronfein’s death removes a prominent figure from Baltimore’s business and nonprofit communities and raises immediate questions about leadership and continuity at Curio Wellness, the Maryland cannabis company he co-founded with his daughter, Wendy Bronfein, in 2014.

Bronfein’s career traced several major growth sectors in the Baltimore region. He co-founded NeighborCare, which expanded into a national pharmaceutical and clinical-services company, and later helped launch Sterling Partners. In 2014, Bronfein and Wendy Bronfein founded Curio Wellness; the company grew into a prominent player in Maryland’s regulated cannabis market and counts the Far & Dotter retail brand among its holdings. Those ventures tied Bronfein to both the traditional health-care economy and the newer, highly regulated cannabis sector that has become an important source of local jobs and tax revenues in Maryland.

Beyond business, Bronfein was a visible civic actor. He served on the boards of the Greater Baltimore Committee, advised the Johns Hopkins Bloomberg School of Public Health, and supported arts institutions including the Baltimore Symphony Orchestra. Local nonprofits and civic organizations issued statements of condolence and underscored Bronfein’s role as a donor and adviser to projects that intersected public health, the arts and economic development.

Economically, Bronfein’s passing matters because his activities spanned firms that scale employment and channel capital into Baltimore City and surrounding counties. NeighborCare’s expansion into national markets and Curio Wellness’s retail and cultivation operations represent two different business models that together helped create middle-skill jobs, build local supplier networks and contribute to municipal revenues through licensing and taxes. With Bronfein no longer at the helm, Curio Wellness faces a leadership test at a time when Maryland’s cannabis regulatory framework and market competition remain evolving factors for operators.

For Baltimore residents, the immediate impacts will be felt in both civic giving and business continuity. Philanthropic commitments and board participation that Bronfein maintained may be reassessed, and Curio Wellness will need to clarify succession plans to reassure employees and partners. The business community and nonprofit sector will also be watching how Bronfein’s absence affects ongoing collaborations between private firms and public health institutions.

Family members and civic leaders have expressed condolences and noted Bronfein’s long record of service. In the coming weeks, expect local organizations and Curio Wellness to provide more detail on memorials and operational plans. The city loses a builder of businesses and institutions, and the next chapter will test how closely Bronfein’s enterprises and the causes he backed can sustain the momentum he helped create.